Sensitive quantification of fibroblast activation protein and high-throughput screening for inhibition by FDA-approved compounds
Kateřina Čermáková, Adéla Šimková, Filip Wichterle, Robin Kryštůfek, Jana Staňurová, Zdislava Vaníčková, Petr Bušek, Jan Konvalinka, Pavel Šácha
The paper presents a qPCR-based method for high-throughput screening of FDA-approved compounds as FAP inhibitors and demonstrates its application in quantifying FAP in human plasma.
European Journal of Medicinal Chemistry · Oct 9, 2024Peer-reviewedBiochemistry